Here's What Medicare Part A Costs in 2026

Medicare Part A cost-sharing levels rise for 2026: the inpatient deductible increases to $1,736 (from $1,676), hospital coinsurance for days 61–90 rises to $434/day (from $419), lifetime reserve day coinsurance to $868/day (from $838), and skilled nursing coinsurance to $217/day (from $209.50). While most enrollees continue to pay no Part A premium, higher deductibles and per‑day coinsurance materially raise out‑of‑pocket exposure for beneficiaries and increase the importance of Medigap or supplemental coverage, with secondary implications for retirement planning and federal health outlays.

Analysis

Market structure: Incremental 2026 Part A cost increases shift value toward supplemental-payors and Medicare Advantage (MA) providers. Winners include large managed-care/Medigap writers (UnitedHealth UNH, Humana HUM, Elevance ELV, CVS CVS) who can price ancillary products and capture enrollments; losers are skilled-nursing operators/REITs (Omega Healthcare OHI, LTC Properties LTC) and price-sensitive post-acute providers as SNF utilization and elective long stays face marginal demand friction.

Risks & timing: Near-term (days–weeks) market impact is muted; key short-term windows are CMS guidance releases and state Medicaid enrollment prints in next 30–90 days. Tail risks include regulatory intervention (Congress/CMS capping Medigap commissions or altering Part A funding) and a politically-driven reimbursement reset—low probability but high impact for insurers and REITs over quarters–years.

Trade implications: Expect modest margin expansion for MA/Medigap carriers if enrollment shifts accelerate—favor long, scale-in positions into earnings and Oct 2026 Open Enrollment signals. Short SNF/long-term care real estate exposure where coinsurance sensitivity is highest. Use defined-risk option structures into key catalysts (CMS notices, Q1 2026 results).

Contrarian view: The market may overstate demand destruction; elderly inpatient care is relatively inelastic so utilization drop may be 5–10% at most while voluntary uptake of Medigap/MA could rise 3–7pp, favoring insurers. Watch unintended state-level Medicaid spillover: a >2% uptick in Medicaid caseloads would stress muni budgets and create second-order risk for state healthcare credits.

Key Decisions for Investors

• Establish a 2.5% total long position split UNH (1.25%) and HUM (1.25%) over the next 4–8 weeks; target +20% in 12 months, trim at +25% or stop-loss at -12% if margin guidance deteriorates by >50bps on a quarter.
• Implement a pair trade: go long HUM (1.5%) and short OHI (1.5%) to express Medigap/MA upside vs SNF downside; cover if OHI falls >20% or HUM underperforms peers by >10% on identical catalysts.
• Buy defined-risk call spreads on UNH or ELV with 9–15 month expiries (LEAP-style) sized to 0.5–1.0% of portfolio—target asymmetric upside while capping premium to <2% of portfolio; roll or exit after CMS enrollment data (Oct 2026) or on 30% realized gain.
• Reduce exposure to skilled-nursing/healthcare REITs (OHI, LTC) by 40–60% within 30 days and redeploy into managed-care names or cash if state Medicaid enrollment rises >1.5% quarter-over-quarter; monitor CMS Part A/MA payment notices and state Medicaid caseloads over next 60 days before adding net longs.